Last 4,867 INR
Change Today +41.90 / 0.87%
Volume 3.0K
SKB On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 07/28/14 All times are local (Market data is delayed by at least 15 minutes).

glaxosmithkline consumer hea (SKB) Snapshot

Open
4,800
Previous Close
4,825
Day High
4,888
Day Low
4,776
52 Week High
07/29/13 - 5,009
52 Week Low
09/3/13 - 3,801
Market Cap
204.7B
Average Volume 10 Days
5.4K
EPS TTM
--
Shares Outstanding
42.1M
EX-Date
07/28/14
P/E TM
--
Dividend
45.00
Dividend Yield
0.92%
Current Stock Chart for GLAXOSMITHKLINE CONSUMER HEA (SKB)

Related News

No related news articles were found.

glaxosmithkline consumer hea (SKB) Related Businessweek News

No Related Businessweek News Found

glaxosmithkline consumer hea (SKB) Details

GlaxoSmithKline Consumer Healthcare Limited operates in the health food drinks industry in India. It manufactures and markets health food drinks, nutritional supplements, biscuits, and choco-malt drinks under the Horlicks, Boost, Maltova, and Viva brand names. The company also offers over-the-counter medicine, including Crocin, a pain and body ache relieving drug; Crocin Pain Relief, a pain relief medicine; Crocin Cold and Flu, which provides relief from cold; and Crocin paediatric medicines for infants, toddlers, and older kids up to 12 years. In addition, it provides Eno, an antacid for acidity, gastric discomfort, and heat burn; and Iodex for head, neck, back joint, and muscular pains, as well as Iodex creams and gels; and oral care products under the Sensodyne brand name. The company exports its products to Pakistan, Myanmar, Sri Lanka, Bangladesh, the Middle East, Nepal, Kenya, and Malaysia. GlaxoSmithKline Consumer Healthcare Limited was incorporated in 1958 and is headquartered in Gurgaon, India.

3,502 Employees
Last Reported Date: 07/11/14
Founded in 1958

glaxosmithkline consumer hea (SKB) Top Compensated Officers

Managing Director, Executive Director and Mem...
Total Annual Compensation: 97.4M
Director of Finance, Wholetime Director, Memb...
Total Annual Compensation: 36.7M
Director of Operations, Wholetime Director an...
Total Annual Compensation: 36.4M
Compensation as of Fiscal Year 2014.

glaxosmithkline consumer hea (SKB) Key Developments

GlaxoSmithKline Consumer Healthcare Limited - Shareholder/Analyst Call

GlaxoSmithKline Consumer Healthcare Limited - Shareholder/Analyst Call

GlaxoSmithKline Consumer Healthcare Limited Announces Unaudited Earnings Results for the Fourth Quarter and Audited Earnings Results for the Fifteen Months Ended March 31, 2014

GlaxoSmithKline Consumer Healthcare Limited announced unaudited earnings results for the fourth quarter and audited earnings results for the fifteen months ended March 31, 2014. For the quarter, the company reported net sales of INR 10,790.90 million compared with INR 9,398.6 million for the same period a year ago. Profit from operation before other income, finance cost and exceptional items was INR 2,131.4 million compared with INR 1,956.0 million for the same period a year ago. Profit from ordinary activities before tax was INR 2,609.7 million compared with INR 2,279.0 million for the same period a year ago. Net profit was INR 1,717.1 million or INR 40.83 per basic and diluted share before and after extraordinary items compared with INR 1,564.1 million or INR 37.19 per basic and diluted share before and after extraordinary items for the same period a year ago. For the fifteen months, the company reported net sales of INR 46,829.2 million compared with INR 30,793.6 million for the same period a year ago. Profit from operation before other income, finance cost and exceptional items was INR 8,102.3 million compared with INR 5,373.3 million for the same period a year ago. Profit from ordinary activities before tax was INR 10,160.9 million compared with INR 6,487.0 million for the same period a year ago. Net profit was INR 6,747.6 million or INR 160.44 per basic and diluted share before and after extraordinary items compared with INR 4,367.7 million or INR 103.85 per basic and diluted share before and after extraordinary items for the same period a year ago.

GlaxoSmithKline Consumer Healthcare Limited Recommends Dividend, Payable on or Before September 05, 2014

GlaxoSmithKline Consumer Healthcare Limited announced that the Board of Directors of the company at its meeting held on May 09, 2014, recommended a Dividend at the rate of INR 45 per equity share of INR 10 each. The dividend shall be paid to the entitled Members on or before September 05, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SKB:IN 4,866.50 INR +41.90

SKB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arena Pharmaceuticals Inc $4.61 USD -0.16
DC Brands International Inc $0.0001 USD 0.00
Perrigo Co PLC $153.84 USD -1.15
VIVUS Inc $4.82 USD 0.00
View Industry Companies
 

Industry Analysis

SKB

Industry Average

Valuation SKB Industry Range
Price/Earnings 39.0x
Price/Sales 5.1x
Price/Book 11.1x
Price/Cash Flow 35.5x
TEV/Sales 4.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE CONSUMER HEA, please visit www.gsk-ch.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.